This inventor holds 1 USPTO granted patent. Top assignee: Ortho-Mcneil Pharmaceutical Corp.. Active years: 2008.
Company Filing History:
Years Active: 2008
Title: Öm Almarssoo: Innovator in Pharmaceutical Compositions
Introduction
Öm Almarssoo is a notable inventor based in Shrewsbury, MA (US). He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on topiramate salts and their applications.
Latest Patents
Öm Almarssoo holds a patent for "Topiramate salts and compositions comprising and methods of making and using the same." This invention encompasses novel salts of topiramate, including pharmaceutically acceptable polymorphs, solvates, hydrates, dehydrates, co-crystals, anhydrous, or amorphous forms. The patent also covers pharmaceutical compositions and unit dosage forms containing these salts. Notably, it includes various pharmaceutically acceptable salts of topiramate, such as topiramate sodium, topiramate lithium, and topiramate potassium. Furthermore, the invention outlines methods for treating or preventing a range of diseases and conditions, including seizures, obesity, migraines, and more.
Career Highlights
Öm Almarssoo is associated with Ortho-McNeil Pharmaceutical Corporation, where he has been instrumental in advancing pharmaceutical research and development. His work has led to the creation of innovative treatments that address various medical conditions.
Collaborations
Throughout his career, Öm has collaborated with notable colleagues, including Jules Remenar and Matthew Lynn Peterson. These partnerships have contributed to the success of his projects and the advancement of pharmaceutical science.
Conclusion
Öm Almarssoo's contributions to the field of pharmaceuticals, particularly through his patent on topiramate salts, highlight his role as an innovator in the industry. His work continues to impact the treatment of various medical conditions, showcasing the importance of innovation in healthcare.